Recent News

• 03.27.2025 - BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
• 03.27.2025 - BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
• 03.27.2025 - BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
• 03.25.2025 - Ashok Kumar
• 03.25.2025 - Ashok Kumar
• 03.25.2025 - Christopher Howerton
• 03.25.2025 - Christopher Howerton
• 03.24.2025 - Elemer Piros
• 03.24.2025 - Elemer Piros
• 03.11.2025 - BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

Recent Filings

• 03.27.2025 - 8-K Current report
• 03.27.2025 - EX-99.1 EX-99.1
• 03.21.2025 - 8-K Current report
• 03.21.2025 - 8-K Current report
• 03.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2025 - 4 Statement of changes in beneficial ownership of securities